Year |
Citation |
Score |
2019 |
Stach C, McCann M, O'Brien C, Le TS, Somia N, Chen X, Lee K, Fu HY, Daoutidis P, Zhao L, Hu WS, Smanski MJ. Model-driven engineering of N-linked glycosylation in Chinese Hamster Ovary cells. Acs Synthetic Biology. PMID 31596566 DOI: 10.1021/Acssynbio.9B00215 |
0.376 |
|
2018 |
O'Brien SA, Lee K, Fu HY, Lee Z, Le TS, Stach CS, McCann MG, Zhang AQ, Smanski MJ, Somia NV, Hu WS. Single Copy Transgene Integration in a Transcriptionally Active Site for Recombinant Protein Synthesis. Biotechnology Journal. e1800226. PMID 30024101 DOI: 10.1002/Biot.201800226 |
0.438 |
|
2016 |
Podetz-Pedersen KM, Olson ER, Somia NV, Russell SJ, McIvor RS. A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase. Molecular Therapy. Nucleic Acids. 5: e279. PMID 26784638 DOI: 10.1038/Mtna.2015.54 |
0.33 |
|
2015 |
Boso G, Somia NV. Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line. Plos One. 10: e0121455. PMID 25811758 DOI: 10.1371/Journal.Pone.0121455 |
0.528 |
|
2015 |
Multhaup MM, Podetz-Pedersen KM, Karlen AD, Olson ER, Gunther R, Somia NV, Blazar BR, Cowan MJ, McIvor RS. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency. Human Gene Therapy. 26: 232-43. PMID 25738323 DOI: 10.1089/Hum.2014.062 |
0.365 |
|
2015 |
Boso G, Örvell C, Somia NV. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles. Journal of Virology. 89: 1286-97. PMID 25392207 DOI: 10.1128/Jvi.02312-14 |
0.336 |
|
2014 |
Podetz-Pedersen KM, Vezys V, Somia NV, Russell SJ, McIvor RS. Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo. Human Gene Therapy. 25: 955-65. PMID 25093708 DOI: 10.1089/Hum.2014.048 |
0.349 |
|
2014 |
Hackett PB, Somia NV. Delivering the second revolution in site-specific nucleases. Elife. 3: e02904. PMID 24843032 DOI: 10.7554/Elife.02904 |
0.355 |
|
2013 |
Le H, Vishwanathan N, Kantardjieff A, Doo I, Srienc M, Zheng X, Somia N, Hu WS. Dynamic gene expression for metabolic engineering of mammalian cells in culture. Metabolic Engineering. 20: 212-20. PMID 24055788 DOI: 10.1016/J.Ymben.2013.09.004 |
0.412 |
|
2013 |
Boso G, Tasaki T, Kwon YT, Somia NV. The N-end rule and retroviral infection: no effect on integrase. Virology Journal. 10: 233. PMID 23849394 DOI: 10.1186/1743-422X-10-233 |
0.328 |
|
2012 |
Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Friedmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem HP, et al. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1084-94. PMID 22652996 DOI: 10.1038/Mt.2012.93 |
0.362 |
|
2011 |
Multhaup MM, Gurram S, Podetz-Pedersen KM, Karlen AD, Swanson DL, Somia NV, Hackett PB, Cowan MJ, McIvor RS. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo. Dna and Cell Biology. 30: 751-61. PMID 21663454 DOI: 10.1089/Dna.2011.1244 |
0.448 |
|
2011 |
Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Research. 39: e82. PMID 21493687 DOI: 10.1093/Nar/Gkr218 |
0.332 |
|
2011 |
Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proceedings of the National Academy of Sciences of the United States of America. 108: 260-5. PMID 21173221 DOI: 10.1073/Pnas.1013343108 |
0.364 |
|
2010 |
Multhaup M, Karlen AD, Swanson DL, Wilber A, Somia NV, Cowan MJ, McIvor RS. Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. Human Gene Therapy. 21: 865-75. PMID 20163250 DOI: 10.1089/Hum.2009.162 |
0.477 |
|
2010 |
Iizuka YM, Somia NV, Iizuka K. Identification of NK cell receptor ligands using a signaling reporter system. Methods in Molecular Biology (Clifton, N.J.). 612: 285-97. PMID 20033648 DOI: 10.1007/978-1-60761-362-6_19 |
0.314 |
|
2007 |
Lech P, Somia NV. Isolation and characterization of human cells resistant to retrovirus infection. Retrovirology. 4: 45. PMID 17608937 DOI: 10.1186/1742-4690-4-45 |
0.518 |
|
2007 |
Gori JL, Podetz-Pedersen K, Swanson D, Karlen AD, Gunther R, Somia NV, McIvor RS. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase. The Journal of Pharmacology and Experimental Therapeutics. 322: 989-97. PMID 17586722 DOI: 10.1124/Jpet.107.123414 |
0.417 |
|
2006 |
Agarwal S, Harada J, Schreifels J, Lech P, Nikolai B, Yamaguchi T, Chanda SK, Somia NV. Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proceedings of the National Academy of Sciences of the United States of America. 103: 15933-8. PMID 17043244 DOI: 10.1073/Pnas.0602674103 |
0.644 |
|
2006 |
Agarwal S, Nikolai B, Yamaguchi T, Lech P, Somia NV. Construction and use of retroviral vectors encoding the toxic gene barnase. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 555-63. PMID 16814610 DOI: 10.1016/J.Ymthe.2006.03.025 |
0.665 |
|
2006 |
Score PR, Belur LR, Frandsen JL, Geurts JL, Guerts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 617-24. PMID 16356773 DOI: 10.1016/J.Ymthe.2005.10.015 |
0.388 |
|
2006 |
Gori JL, Podetz-Pederson K, Swanson D, Karlin AD, Somia NV, Scott McIvor R. 773. Chemoprotection of Mouse Marrow Transplant Recipients by Ex Vivo Lentiviral Transduction of Murine tyr22 Dihydrofolate Reductase Conferring Resistance to Methotrexate Molecular Therapy. 13: S299. DOI: 10.1016/J.Ymthe.2006.08.859 |
0.442 |
|
2005 |
McIvor RS, Somia NV, Converse AD. 826. The Risk of Integration: Characterization and Testing of Cell Lines Engineered for the Study of Insertional Gene Activation Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.369 |
0.449 |
|
2004 |
Somia N. Gene delivery to cells in culture using retroviruses. Methods of Molecular Biology. 246: 491-498. PMID 14970612 DOI: 10.1385/1-59259-650-9:491 |
0.487 |
|
2004 |
Somia NV. Gene Transfer by Retroviral Vectors Methods of Molecular Biology. 246: 463-490. PMID 14970611 DOI: 10.1385/1-59259-650-9:463 |
0.413 |
|
2004 |
Converse AD, Somia NV, McIvor RS. 7. The Risk of Integration: Cell Lines for Determining the Frequency and Character of Vector-Mediated Insertional Gene Activation Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.088 |
0.49 |
|
2001 |
Tan S, Somia N, Maher P, Schubert D. Regulation of antioxidant metabolism by translation initiation factor 2alpha. The Journal of Cell Biology. 152: 997-1006. PMID 11238455 DOI: 10.1083/Jcb.152.5.997 |
0.339 |
|
2000 |
Somia N, Verma IM. Gene therapy: Trials and tribulations Nature Reviews Genetics. 1: 91-99. PMID 11253666 DOI: 10.1038/35038533 |
0.323 |
|
2000 |
Somia NV, Miyoshi H, Schmitt MJ, Verma IM. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping. Journal of Virology. 74: 4420-4. PMID 10756057 DOI: 10.1128/Jvi.74.9.4420-4424.2000 |
0.463 |
|
1999 |
Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma IM. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proceedings of the National Academy of Sciences of the United States of America. 96: 12667-72. PMID 10535980 DOI: 10.1073/Pnas.96.22.12667 |
0.363 |
|
1999 |
Somia NV, Kafri T, Verma IM. Piecing together more efficient gene expression Nature Biotechnology. 17: 224-225. PMID 10096283 DOI: 10.1038/6962 |
0.39 |
|
1997 |
Verma IM, Somia N. Gene therapy -- promises, problems and prospects. Nature. 389: 239-42. PMID 9305836 DOI: 10.1038/38410 |
0.374 |
|
1995 |
Somia NV, Zoppé M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proceedings of the National Academy of Sciences of the United States of America. 92: 7570-4. PMID 7638232 DOI: 10.1073/Pnas.92.16.7570 |
0.494 |
|
1993 |
Somia NV, Jessop JK, Melton DW. Phenotypic correction of a human cell line (46BR) with aberrant DNA ligase I activity Mutation Research-Dna Repair. 294: 51-58. PMID 7683758 DOI: 10.1016/0921-8777(93)90057-N |
0.329 |
|
Show low-probability matches. |